Rattiya Phianpiset

Dr. Rattiya Phianpiset


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2022 in Asia-Pacific Journal of Clinical Oncology
Verified
Journal Article
Closed access
RPRattiya Phianpiset
Rattiya Phianpiset
IRIrene Ruengkhachorn
Irene Ruengkhachorn
SKSompop Kuljarusnont
Sompop Kuljarusnont
NJNida Jareemit
Nida Jareemit
SUSuthipol Udompunturak
Suthipol Udompunturak

26 July 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PIPornporm Ittiamornlert
Pornporm Ittiamornlert
NJNida Jareemit
Nida Jareemit
RPRattiya Phianpiset
Rattiya Phianpiset
SKSompop Kuljarusnont
Sompop Kuljarusnont
SHSuchanan Hanamornroongruang
Suchanan Hanamornroongruang
IRIrene Ruengkhachorn
Irene Ruengkhachorn
We conducted a prospective study to evaluate the prevalence of high-risk human papillomavirus (hr-HPV) positivity in women with atypical squamous cells of undetermined significance (ASC-US). Additionally, we assessed the association of hr-HPV positivity with the pathology of high-grade squamous intraepithelial lesions or worse (HSIL+) and the risk of subsequent detection of squamous intraepithelial lesions. A total of 376 women were included, with 242 (64.4%) exhibiting hr-HPV positivity. The predominant HPV genotypes were 16, 52 and 58. Factors associated with the immediate detection of HSIL+ pathology included a colposcopic impression of high-grade lesions, hr-HPV positivity, HPV 16 positivity, HPV 18 positivity, HPV 58 positivity, age less than 40 years, and biopsy of two or more pieces. However, only the first three factors were statistically significant in multivariate analysis. Among the 291 women who continued surveillance for 6 months or more, the median follow-up period was 41.8 months (interquartile range [IQR] 26.5–54.0). The prevalence of subsequent HSIL in women with hr-HPV positivity versus negativity was 3.6% versus 0.98%, respectively. The median time to the subsequent detection of SIL was 28.7 months (IQR 14.9–41.7). In conclusion, women with ASC-US in our study had a high proportion of hr-HPV positivity. Type-specific HPV testing could play a pivotal role in the development of specific management protocols for women with ASC-US.Clinical trial registration: https://thaiclinicaltrials.org, TCTR20161017002.

11 December 2025 in Cancers
Verified
Journal Article
Open access
PDF file
RPRattiya Phianpiset
Rattiya Phianpiset
CDChayanid Detwongya
Chayanid Detwongya
SPSunisa Phookiaw
Sunisa Phookiaw
MMManatsawee Manopunya
Manatsawee Manopunya
CPChailert Phongnarisorn
Chailert Phongnarisorn
Kittipat CharoenkwanKittipat Charoenkwan
Kittipat Charoenkwan
Objective: To assess the oncological outcomes of laparoscopic versus open radical hysterectomy (RH) in patients with early-stage cervical cancer using propensity score–matched analysis. Methods: We conducted a retrospective cohort study of 1244 patients who underwent RH with pelvic lymphadenectomy at Chiang Mai University Hospital between 2003 and 2019. Of these, 82 patients received a laparoscopic approach (LAP) and 1162 underwent open radical hysterectomy. Propensity-score matching was performed in a 1:4 ratio using a caliper of 0.2 standard deviations to achieve balance between groups. Overall survival (OS) and progression-free survival (PFS) were analyzed with Kaplan–Meier curves and the log-rank test. Subgroup analysis was conducted based on tumor size (≤ 2 cm vs. > 2 cm). In addition, multivariable Cox proportional hazards models incorporating all relevant clinical and pathological variables were applied to the overall cohort to assess independent predictors of OS and PFS. Results: After matching, 72 LAP RH cases were compared with 279 open RH cases, showing well-balanced baseline features. At 5 years, OS was nearly the same between the LAP and the open groups (95.8% vs. 95.5%; p = 0.95), and PFS was also similar (92.3% vs. 93.8%; p = 0.85). Subgroup analyses demonstrated that LAP RH did not result in a survival disadvantage for tumors ≤ 2 cm or > 2 cm. In multivariable Cox analysis, surgical approach was not an independent predictor of (HR 0.83, 95% CI 0.40–1.71, p = 0.61) or PFS (HR 1.12, 95% CI 0.44–2.84, p = 0.82). Conclusions: In our single-center cohort analyzed using propensity score matching, LAP RH showed long-term oncological outcomes comparable to those of open RH. These results support LAP RH as a safe surgical option for selected patients with early-stage cervical cancer within our setting, where procedures were performed by experienced surgeons following standardized techniques. Further evaluation in diverse clinical contexts is still needed.

1 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
RPRattiya Phianpiset
Rattiya Phianpiset
CDChayanid Detwongya
Chayanid Detwongya
MMManatsawee Manopunya
Manatsawee Manopunya
Chalong CheewakriangkraiChalong Cheewakriangkrai
Chalong Cheewakriangkrai
Kittipat CharoenkwanKittipat Charoenkwan
Kittipat Charoenkwan
Background: Radical hysterectomy with pelvic lymphadenectomy is a standard surgical procedure for early-stage cervical cancer. However, even with optimal treatment, some patients still experience disease recurrence. We aimed to develop and validate a prediction model to classify patients according to the risk of recurrence which can better assist clinicians to tailor the postoperative treatment and improve patient outcomes. Methods: Data of women diagnosed with early-stage cervical cancer who underwent radical hysterectomy were collected and analyzed. The primary outcome was recurrence-free survival (RFS). A prediction model based on Cox proportional hazard regression was developed by using the backward elimination procedure. Internal validation was performed by bootstrapping. The model’s discriminative ability was demonstrated by the concordance index (C-index). The model’s calibration was examined through a calibration plot. The final prognostic model was presented as a nomogram and a web-based calculator, which were further used to categorize patients into low, moderate, and high-risk groups for clinical application. Results: Among the 1309 patients, 115 (8.8%) experienced a recurrence. The median follow-up was 72.2 months. The 3-year and 5-year RFS rates were 93.0% (95% CI, 91.5–94.6%) and 90.7% (95% CI, 88.9–92.5%), respectively. Tumor size, histological subtype, number of positive lymph nodes, lymphovascular space invasion, and platelet-to-lymphocyte ratio were significantly associated with RFS. These factors were employed to construct a prediction model. The model exhibited a good overall fit with minimal overfitting and good calibration. The model’s discriminative performance, as measured by the C-index, was 0.73. Conclusions: Our proposed survival model offers a potentially valuable tool for therapeutic decision-making in patients with early-stage cervical cancer. This model demonstrates robust discriminative performance and predictive calibration. Nevertheless, external validation across diverse datasets should be conducted to assess the reproducibility and applicability of this predictive model across a broader spectrum of patients.

1 December 2023 in Biomedical Sciences and Clinical Medicine
Verified
Journal Article
Open access
PDF file
PSPrapaporn Suprasert
Prapaporn Suprasert
VCVarisa Chuenchitkultavorn
Varisa Chuenchitkultavorn
RPRattiya Phianpiset
Rattiya Phianpiset
ARATHITHAN RATTANABURI
ATHITHAN RATTANABURI
AAApiwat Aue-Aungkul
Apiwat Aue-Aungkul
WKWarangkana Kolaka
Warangkana Kolaka
OBJECTIVE To evaluate the knowledge, attitudes, practices (KAP), and acceptance of gynecologic cancer patients from the 4 regions of Thailand related to the COVID-19 vaccine. METHODS Gynecologic cancer patients from Chiang Mai University Hospital, Khon Kaen University Hospital, Khon Kaen Hospital, Prince of Songkhla University Hospital, and the National Cancer Institute (NCI) in Bangkok were surveyed using a WHO survey instrument. RESULTS Between February and September 2022, 1,263 patients partici-pated in this project of whom 1,084 (85.8%) had received the COVID-19 vaccine. The highest rate of vaccination was the NCI followed by Khon Kaen, Chiang Mai, and Songkhla. Of the participants, 28.2% were infected with COVID-19 and 12.9% of the infected participants were unvaccinated. Regarding KAP, the average scale level of overall participants reported ease in obtaining health literacy, a moderate probability of having severe COVID-19 infection, knowledge and adoption of proper appropriate behavior for the prevention of COVID infection, little stress regarding possible COVID-19 infection, and quite a lot of a significant level of trust in healthcare workers. Most participants generally agreed with the lifting of some regular rules to reduce the risk of infection and often many expressed a feeling of general well-being. The significantly different levels of rating scale by unvaccinated and vaccinated participants in the key areas were as follows: (Patients rated each of the areas investigated on a scale of 0 to 6, with 0 indicating lowest level of agreement/acceptance and 6 indicating the highest level) health ministry recommendations (3.92 vs. 4.16), ease of getting the COVID vaccine (3.6 vs. 3.9), “no need to receive the vaccine due to the disease being rare” (2.6 vs. 2.2), “stress made me not want to get vaccinated” (2.6 vs. 2.1), “if everyone is vaccinated, no need for me to vaccinate” (2.5 vs. 1.9), and the importance of COVID-19 vaccines (3.7 vs. 4.2). CONCLUSIONS Most gynecologic cancer patients from the 4 regions of Thailand had received the COVID-19 vaccine and exhibited good knowledge, attitudes, and practices related to this pandemic. KEYWORDS COVID-19-vaccine, gynecologic cancer patients, attitude, practice